← Back to Search

BP REACH Intervention for High Blood Pressure (BP-REACH Trial)

N/A

Recruiting

Led By Alejandra Casillas, MD

Research Sponsored by University of Southern California

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients of LA General Medical Center, Rancho Los Amigos, Olive Medical Center or Harbor-UCLA Medical Center with ischemic stroke, hemorrhagic stroke, or myocardial infarction

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

BP-REACH Trial Summary

This trial is testing a team-based program to help reduce blood pressure for heart attack and stroke survivors. Participants get follow up with a pharmacist, education, and monthly phone calls from a health coach.

Who is the study for?

This trial is for English or Spanish speakers over 35 years old with high blood pressure (SBP ≥ 130 mm Hg) who have had a stroke or heart attack and are patients at specific LA medical centers. It's not for those who can't consent due to conditions like dementia.Check my eligibility

What is being tested?

The BP REACH Intervention, a team-based program involving pharmacists and health coaches, aims to lower blood pressure in people with past strokes or heart attacks. It will be compared to usual care over a period of 12 months.See study design

What are the potential side effects?

Since the intervention involves lifestyle coaching and medication management rather than new drugs, side effects may be minimal but could include potential stress from lifestyle changes.

BP-REACH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I had a stroke or heart attack and am a patient at one of the specified medical centers.

BP-REACH Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Systolic blood pressure (SBP) mmHG

Secondary outcome measures

BMI (body mass index)

Diet

HgbA1c (hemoglobin A1C)

+4 more

BP-REACH Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Participants follow the intervention protocol, including receiving educational materials, a home blood pressure monitor, coaching calls from BP REACH coaches and medication management from a pharmacist.

Group II: Usual CareActive Control1 Intervention

Participants receive the usual care received by patients of the medical center

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor

906 Previous Clinical Trials

1,595,176 Total Patients Enrolled

University of California, Los AngelesOTHER

1,532 Previous Clinical Trials

10,264,268 Total Patients Enrolled

University of California, IrvineOTHER

544 Previous Clinical Trials

1,922,043 Total Patients Enrolled

Media Library

Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05937685 — N/A

High Blood Pressure Research Study Groups: Usual Care, Intervention

High Blood Pressure Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05937685 — N/A

Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05937685 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

At what number of sites is this experiment overseen?

"This study is recruiting in 4 locations, including the LA General Medical Center situated in Los Angeles, Olive View Medical Centre located in Sylmar and Harbor UCLA Medical Centre stationed in Torrance. Additionally, there are an additional four sites that are also onboarding patients."

Answered by AI

Are there any active enrollments happening in this clinical trial?

"According to clinicaltrials.gov, the trial is no longer seeking enrolment. Initially posted on July 1st 2023 and last edited on June 30th 2023, this research is presently not open for recruitment. However, there are currently 2,130 other medical studies that need patients at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Reducing Blood Pressure in Patients With High Cardiovascular Risk in the Safety-Net

Amytis Towfighi 2023. "Reducing Blood Pressure in Patients With High Cardiovascular Risk in the Safety-Net". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05937685.

All > Heart Attack > High Blood Pressure